Rectal cancer drug trial of dostarlimab cures all patients: report
Ann Schmidt, article, c94130f7-1a8c-5820-a840-37bb6be61abb, fnc, Fox News, fox-news/good-news, fox-news/health, fox-news/health/cancer, fox-news/health/medical-research, fox-news/lifestyle, News
A clinical trial of dostarlimab, done by Memorial Sloan Kettering Cancer Center, found the drug appears to have completely cured 12 patients of rectal cancer.